Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm – author's reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|7|943-944

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.7, 2015-10, pp. : 943-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 942-943

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: clarithromycin dose for H. pylori therapy remains unresolved

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 631-632

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: clarithromycin dose for H. pylori therapy remains unresolved – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 632-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

The above letter was referred to the author of the original paper, and Dr. Finucane's reply follows

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 12, 1991-12 ,pp. : 1243-1244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: increasing incidence and prevalence of eosinophilic oesophagitis – author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 125-125

John Wiley & Sons Inc

Access to resources Recommend Favorite